Skip to Content

Trilipix Approval History

FDA Approved: Yes (First approved December 15, 2008)
Brand name: Trilipix
Generic name: fenofibric acid
Dosage form: Delayed-Release Capsules
Company: Abbott
Treatment for: Hypertriglyceridemia, High Cholesterol

Trilipix (fenofibric acid) is a peroxisome proliferator receptor alpha (PPARĪ±) activator indicated for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. Trilipix is the first and only fibrate to be approved for use in combination with a statin.

Development History and FDA Approval Process for Trilipix

DateArticle
Dec 15, 2008Approval Abbott Receives FDA Approval for Trilipix (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide